Search Results

5476 - 5500 of 56346
TitleWireDateTime
Nasus Pharma to Present Topline Analysis from NS002 Intranasal Epinephrine Powder Phase 2 Single and Repeat Dose Clinical Study Globe Newswire 03/09 08:30
Hudson Technologies to Attend 38th Annual Roth Conference Globe Newswire 03/09 08:30
First-ever Dental Dedicated MRI Validated in Clinical Trial and Cleared by FDA for Advanced Soft-Tissue Diagnostics Globe Newswire 03/09 08:30
SS Innovations Announces Completion of an $18.6 Million Private Placement to Support Growth Initiatives Globe Newswire 03/09 08:30
Powell Max Limited Successfully Repositions for Its Next Phase of Growth Globe Newswire 03/09 08:30
Jet.AI Inc. Reports Full Year 2025 Financial Results Globe Newswire 03/09 08:30
UPDATE – Visionary Doubles Down on High-Margin Medical Aesthetics with US$12 Million Exclusive Agreement, Initiates Strategic Exit from Non-Core Businesses Globe Newswire 03/09 08:30
Capricor Therapeutics to Present Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Update on March 12 Globe Newswire 03/09 08:30
Aurora Mobile's EngageLab Launches OpenClaw Skills, Empowering AI Agents to Connect with the Real World Globe Newswire 03/09 08:30
Eagle Nuclear Energy Corp. to Ring Nasdaq Opening Bell on March 11 Globe Newswire 03/09 08:30
Jeffs' Brands: KeepZone AI Enters into Channel Partner Agreement for 4G/5G Infrastructure Globe Newswire 03/09 08:20
Safe Harbor Financial CEO Highlights Growth Platform Launch, Debt Elimination, and Financial Stabilization in Letter to Shareholders Globe Newswire 03/09 08:17
Adeia Enters into Multi-Year IP License Agreement with AMD Globe Newswire 03/09 08:06
Acronis Releases 2025 ESG Report Highlighting Progress in Sustainability, Workforce Engagement, and Responsible Technology Globe Newswire 03/09 08:05
Sangamo Therapeutics Advances Rolling Submission of BLA to U.S. FDA for ST-920 in Fabry Disease Globe Newswire 03/09 08:05
AVAX One To Participate in the Digital Chamber’s DC Blockchain Summit 2026 Globe Newswire 03/09 08:05
Candel Therapeutics To Present New Data after Extended Follow Up from Randomized Phase 3 Trial of Aglatimagene Besadenovec in Localized Prostate Cancer at the American Urological Association 2026 Annual Meeting Globe Newswire 03/09 08:05
Cue Biopharma to Present New In vitro Data for CUE-401 at the 20th World Immune Regulation Meeting (WIRM) 2026 Globe Newswire 03/09 08:00
Byrna Technologies Announces Preliminary Fiscal First Quarter Revenues of $29.0 Million Globe Newswire 03/09 08:00
Route 92 Medical Enrolls First Patient in SUMMIT RISE Study Globe Newswire 03/09 08:00
Renewal Fuels, Inc. (OTC: RNWF), Operating as American Fusion, Appoints Andrew S. Mikulski as Independent Director and Provides Patent Portfolio Update for Texatron Fusion Platform Globe Newswire 03/09 08:00
MBX Biosciences Announces Successful End-of-Phase 2 FDA Meeting and Provides Phase 3 Development Plan for Once-Weekly Canvuparatide for Hypoparathyroidism Globe Newswire 03/09 08:00
Nasus Pharma to Present and Participate in the Upcoming Life Sciences Investor Forum Globe Newswire 03/09 08:00
Daxor Corporation to Participate in the iAccess Virtual Alpha Best Ideas Spring Investment Conference 2026 Globe Newswire 03/09 08:00
electroCore to Announce Fourth Quarter and Full Year Ended December 31, 2025, Financial Results on Thursday, March 19, 2026 Globe Newswire 03/09 08:00
5476 - 5500 of 56346

News, Photo and Web Search